tiprankstipranks
Trending News
More News >
Crispr Therapeutics (CRSP)
:CRSP
US Market

Crispr Therapeutics AG (CRSP) Technical Analysis

Compare
9,444 Followers

Technical Sentiment

Overall Consensus
Strong Buy
15Bullish
5Neutral
2Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Crispr Therapeutics’s (CRSP) Moving Averages Convergence Divergence (MACD) indicator is 1.62, suggesting Crispr Therapeutics is a Sell.
Crispr Therapeutics’s (CRSP) 20-Day exponential moving average is 40.74, while Crispr Therapeutics’s (CRSP) share price is $44.25, making it a Buy.
Crispr Therapeutics’s (CRSP) 50-Day exponential moving average is 39.48, while Crispr Therapeutics’s (CRSP) share price is $44.25, making it a Buy.

Crispr Therapeutics AG (CRSP) Pivot Points

Jun 24, 2025, 04:12 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
37.18
39.68
42.05
44.55
46.92
49.42
51.79
Fibonacci
39.68
41.54
42.69
44.55
46.41
47.56
49.42
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Crispr Therapeutics AG (CRSP) Moving Averages

Jun 24, 2025, 04:12 AM
Period
Simple
Exponential
MA5
42.96Buy
43.28Buy
MA10
42.45Buy
42.20Buy
MA20
39.92Buy
40.74Buy
MA50
38.40Buy
39.48Buy
MA100
40.00Buy
40.28Buy
MA200
43.09Buy
43.54Buy
Crispr Therapeutics’s (CRSP) 10-Day exponential moving average is 42.20, while Crispr Therapeutics’s (CRSP) share price is $44.25, making it a Buy.
Crispr Therapeutics’s (CRSP) 100-Day exponential moving average is 40.28, while Crispr Therapeutics’s (CRSP) share price is $44.25, making it a Buy.
Crispr Therapeutics’s (CRSP) stock price is $44.25 and Crispr Therapeutics’s (CRSP) 50-day simple moving average is 38.40, creating a Buy signal.
Crispr Therapeutics’s (CRSP) stock price is $44.25 and Crispr Therapeutics’s (CRSP) 100-day simple moving average is 40.00, creating a Buy signal.
Crispr Therapeutics’s (CRSP) stock price is $44.25 and Crispr Therapeutics’s (CRSP) 200-day simple moving average is 43.09, creating a Buy signal.

Crispr Therapeutics AG (CRSP) Technical Indicators

Jun 24, 2025, 04:12 AM
Name
Value
Implied Action
RSI (14)
68.21
Neutral
STOCH (9,6)
66.10
Neutral
STOCHRSI (14)
76.13
Neutral
MACD (12,26)
1.62
Sell
ADX (14)
22.38
Neutral
Williams %R
-25.44
Buy
CCI (14)
111.19
Sell
ATR (14)
2.35
-
Ultimate Oscillator
48.33
Neutral
ROC
21.93
Buy
Crispr Therapeutics’s (CRSP) Relative Strength Index (RSI) is 68.21, creating a Neutral signal.
Crispr Therapeutics’s (CRSP) Trend Strength Indicator (ADX) is 22.38, creating a Neutral signal.
Crispr Therapeutics’s (CRSP) Commodity Channel Index (CCI) is 111.19, creating a Sell signal.
Crispr Therapeutics’s (CRSP) Price Rate of Change (ROC) is 21.93, creating a Buy signal.

FAQ

Is CRSP a Buy, Hold, or Sell?
Based on CRSP’s technical indicators, CRSP is a Strong Buy.
    What is CRSP’s RSI (14)?
    CRSP’s RSI (14) is 68.21, which suggests CRSP is a Neutral.
      What is CRSP’s MACD?
      CRSP’s MACD is 1.62, which suggests CRSP is a Sell.
        What is CRSP’s 5-day moving average?
        CRSP’s 5-day moving average is 42.96, which suggests CRSP is a Buy.
          What is CRSP’s 20-day moving average?
          CRSP 20-day moving average is 39.92, which suggests CRSP is a Buy.
            What is CRSP’s 50-day moving average?
            CRSP’s 50-day moving average is 38.40, which suggests CRSP is a Buy.
              What is CRSP’s 200-day moving average?
              CRSP’s 200-day moving average is 43.09, which suggests CRSP is a Buy.
                What is CRSP’s Williams % R (14)?
                CRSP’s Williams % R (14) is -25.44, which suggests CRSP is a Buy.
                  What is CRSP’s CCI (14)?
                  CRSP’s CCI (14) is 111.19, which suggests CRSP is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis